125 related articles for article (PubMed ID: 33101065)
1. TFII-I/Gtf2i and Erythro-Megakaryopoiesis.
Gurumurthy A; Wu Q; Nar R; Paulsen K; Trumbull A; Fishman RC; Brand M; Strouboulis J; Qian Z; Bungert J
Front Physiol; 2020; 11():590180. PubMed ID: 33101065
[TBL] [Abstract][Full Text] [Related]
2. A duplicated gene in the breakpoint regions of the 7q11.23 Williams-Beuren syndrome deletion encodes the initiator binding protein TFII-I and BAP-135, a phosphorylation target of BTK.
Pérez Jurado LA; Wang YK; Peoples R; Coloma A; Cruces J; Francke U
Hum Mol Genet; 1998 Mar; 7(3):325-34. PubMed ID: 9466987
[TBL] [Abstract][Full Text] [Related]
3. Consistent hypersocial behavior in mice carrying a deletion of
Martin LA; Iceberg E; Allaf G
Brain Behav; 2018 Jan; 8(1):e00895. PubMed ID: 29568691
[TBL] [Abstract][Full Text] [Related]
4. Essential functions of the Williams-Beuren syndrome-associated TFII-I genes in embryonic development.
Enkhmandakh B; Makeyev AV; Erdenechimeg L; Ruddle FH; Chimge NO; Tussie-Luna MI; Roy AL; Bayarsaihan D
Proc Natl Acad Sci U S A; 2009 Jan; 106(1):181-6. PubMed ID: 19109438
[TBL] [Abstract][Full Text] [Related]
5. TFII-I regulates target genes in the PI-3K and TGF-β signaling pathways through a novel DNA binding motif.
Segura-Puimedon M; Borralleras C; Pérez-Jurado LA; Campuzano V
Gene; 2013 Sep; 527(2):529-36. PubMed ID: 23831514
[TBL] [Abstract][Full Text] [Related]
6. Transcription Factor 2I Regulates Neuronal Development via TRPC3 in 7q11.23 Disorder Models.
Deurloo MHS; Turlova E; Chen WL; Lin YW; Tam E; Tassew NG; Wu M; Huang YC; Crawley JN; Monnier PP; Groffen AJA; Sun HS; Osborne LR; Feng ZP
Mol Neurobiol; 2019 May; 56(5):3313-3325. PubMed ID: 30120731
[TBL] [Abstract][Full Text] [Related]
7. A mouse single-copy gene, Gtf2i, the homolog of human GTF2I, that is duplicated in the Williams-Beuren syndrome deletion region.
Wang YK; Pérez-Jurado LA; Francke U
Genomics; 1998 Mar; 48(2):163-70. PubMed ID: 9521869
[TBL] [Abstract][Full Text] [Related]
8. Essential role of the N-terminal region of TFII-I in viability and behavior.
Lucena J; Pezzi S; Aso E; Valero MC; Carreiro C; Dubus P; Sampaio A; Segura M; Barthelemy I; Zindel MY; Sousa N; Barbero JL; Maldonado R; Pérez-Jurado LA; Campuzano V
BMC Med Genet; 2010 Apr; 11():61. PubMed ID: 20403157
[TBL] [Abstract][Full Text] [Related]
9. Williams-Beuren syndrome-associated transcription factor TFII-I regulates osteogenic marker genes.
Lazebnik MB; Tussie-Luna MI; Hinds PW; Roy AL
J Biol Chem; 2009 Dec; 284(52):36234-36239. PubMed ID: 19880526
[TBL] [Abstract][Full Text] [Related]
10. Intracisternal Gtf2i Gene Therapy Ameliorates Deficits in Cognition and Synaptic Plasticity of a Mouse Model of Williams-Beuren Syndrome.
Borralleras C; Sahun I; Pérez-Jurado LA; Campuzano V
Mol Ther; 2015 Nov; 23(11):1691-1699. PubMed ID: 26216516
[TBL] [Abstract][Full Text] [Related]
11. Disruption of Src Is Associated with Phenotypes Related to Williams-Beuren Syndrome and Altered Cellular Localization of TFII-I.
Sinai L; Ivakine EA; Lam E; Deurloo M; Dida J; Zirngibl RA; Jung C; Aubin JE; Feng ZP; Yeomans J; McInnes RR; Osborne LR; Roder JC
eNeuro; 2015; 2(2):. PubMed ID: 26464974
[TBL] [Abstract][Full Text] [Related]
12. Identification of a putative transcription factor gene (WBSCR11) that is commonly deleted in Williams-Beuren syndrome.
Osborne LR; Campbell T; Daradich A; Scherer SW; Tsui LC
Genomics; 1999 Apr; 57(2):279-84. PubMed ID: 10198167
[TBL] [Abstract][Full Text] [Related]
13. Expression of the transcription factor, TFII-I, during post-implantation mouse embryonic development.
Fijalkowska I; Sharma D; Bult CJ; Danoff SK
BMC Res Notes; 2010 Jul; 3():203. PubMed ID: 20642858
[TBL] [Abstract][Full Text] [Related]
14. DNA methylation profiles in individuals with rare, atypical 7q11.23 CNVs correlate with GTF2I and GTF2IRD1 copy number.
Strong E; Mervis CB; Tam E; Morris CA; Klein-Tasman BP; Velleman SL; Osborne LR
NPJ Genom Med; 2023 Sep; 8(1):25. PubMed ID: 37709781
[TBL] [Abstract][Full Text] [Related]
15. Genomic organization of the genes Gtf2ird1, Gtf2i, and Ncf1 at the mouse chromosome 5 region syntenic to the human chromosome 7q11.23 Williams syndrome critical region.
Bayarsaihan D; Dunai J; Greally JM; Kawasaki K; Sumiyama K; Enkhmandakh B; Shimizu N; Ruddle FH
Genomics; 2002 Jan; 79(1):137-43. PubMed ID: 11827466
[TBL] [Abstract][Full Text] [Related]
16. Isolation and characterisation of GTF2IRD2, a novel fusion gene and member of the TFII-I family of transcription factors, deleted in Williams-Beuren syndrome.
Tipney HJ; Hinsley TA; Brass A; Metcalfe K; Donnai D; Tassabehji M
Eur J Hum Genet; 2004 Jul; 12(7):551-60. PubMed ID: 15100712
[TBL] [Abstract][Full Text] [Related]
17. Identification of GTF2IRD1, a putative transcription factor within the Williams-Beuren syndrome deletion at 7q11.23.
Franke Y; Peoples RJ; Francke U
Cytogenet Cell Genet; 1999; 86(3-4):296-304. PubMed ID: 10575229
[TBL] [Abstract][Full Text] [Related]
18. Alternative splicing and promoter use in TFII-I genes.
Makeyev AV; Bayarsaihan D
Gene; 2009 Mar; 433(1-2):16-25. PubMed ID: 19111598
[TBL] [Abstract][Full Text] [Related]
19. Generation of a mouse model for a conditional inactivation of Gtf2i allele.
Enkhmandakh B; Stoddard C; Mack K; He W; Kaback D; Yee SP; Bayarsaihan D
Genesis; 2016 Jul; 54(7):407-12. PubMed ID: 27194223
[TBL] [Abstract][Full Text] [Related]
20.
López-Tobón A; Shyti R; Villa CE; Cheroni C; Fuentes-Bravo P; Trattaro S; Caporale N; Troglio F; Tenderini E; Mihailovich M; Skaros A; Gibson WT; Cuomo A; Bonaldi T; Mercurio C; Varasi M; Osborne L; Testa G
Sci Adv; 2023 Dec; 9(48):eadh2726. PubMed ID: 38019906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
